Abstract
Mesenchymal stromal cells (MSCs) are a population of adult stem cells that modulate functional state of neighboring tissues. During cell aging, the biological activity of MSC changes, which may affect tissue homeostasis. It is known that reducing the oxygen level in vitro to physiological values typical to a particular cell niche leads to attenuation of some morphological and functional changes associated with aging. This work aimed to study gene expression in MSCs involved in response to physiological hypoxia using a replicative aging model under physiological (5%) and atmospheric (20%) oxygen in cultures. Our results show that significant reduction of proliferative activity of MSCs is observed after 20 passages (~50 cell generations). Regardless of the oxygen, in senescent cells PKM2, SERPINE1, and VEGFA were upregulated while ANKRD37, DDIT4, HIF1A, and TXNIP were downregulated. Also, ADORA2B, BNIPL, CCNG2, EGLN1, MAP3K1, MXI1, and P4HA1 were downregulated under hypoxia. The effect of oxygen was more pronounced at earlier passages both on the cellular and transcription levels. Irrespective of the passage, genes ANGPTL4, GYS1, PKM2, SERPINE1, and TP53 were downregulated under hypoxia. Also, decreased expression was observed for ADM, F10, HMOX1, P4HB, PFKL, SLC16A3 in earlier passages, and for HK2 – in later passages. Upregulation was only observed for ANKRD37, both at early and late cultures.
Similar content being viewed by others
Abbreviations
- HIF:
-
hypoxia-induced factor
- MSCs:
-
mesenchy-mal stromal cells
- PD:
-
population doubling
- SA-β-gal:
-
senescence-associated β-galactosidase
- SASP:
-
senescence-associated secretory phenotype
- senMSCs:
-
senescent MSCs
References
Munoz–Espin, D., and Serrano, M. (2014) Cellular senes–cence: from physiology to pathology, Nat. Rev. Mol. Cell Biol., 15, 482–496.
Lopez–Otin, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2013) The hallmarks of aging, Cell, 153, 1194–1217.
McHugh, D., and Gil, J. (2018) Senescence and aging: causes, consequences, and therapeutic avenues, J. Cell Biol., 217, 65–77.
Campisi, J., and d’Adda di Fagagna, F. (2007) Cellular senescence: when bad things happen to good cells, Nat. Rev. Mol. Cell Biol., 8, 729–740.
Collado, M., Blasco, M. A., and Serrano, M. (2007) Cellular senescence in cancer and aging, Cell, 130, 223–233.
Salama, R., Sadaie, M., Hoare, M., and Narita, M. (2014) Cellular senescence and its effector programs, Genes Dev., 28, 99–114.
Watanabe, S., Kawamoto, S., Ohtani, N., and Hara, E. (2017) Impact of senescence–associated secretory pheno–type and its potential as a therapeutic target for senescence–associated diseases, Cancer Sci., 108, 563–569.
Kuilman, T., and Peeper, D. S. (2009) Senescence–messag–ing secretome: SMS–ing cellular stress, Nat. Rev. Cancer, 9, 81–94.
Coppe, J. P., Desprez, P. Y., Krtolica, A., and Campisi, J. (2010) The senescence–associated secretory phenotype: the dark side of tumor suppression, Annu. Rev. Pathol., 5, 99–118.
Minieri, V., Saviozzi, S., Gambarotta, G., Lo Iacono, M., Accomasso, L., Cibrario Rocchietti, E., Gallina, C., Turinetto, V., and Giachino, C. (2015) Persistent DNA damage–induced premature senescence alters the function–al features of human bone marrow mesenchymal stem cells, J. Cell Mol. Med., 19, 734–743.
Turinetto, V., Vitale, E., and Giachino, C. (2016) Senescence in human mesenchymal stem cells: functional changes and implications in stem cell–based therapy, Int. J. Mol. Sci., 17, E1164.
Wei, F., Qu, C., Song, T., Ding, G., Fan, Z., Liu, D., Liu, Y., Zhang, C., Shi, S., and Wang, S. (2012) Vitamin C treatment promotes mesenchymal stem cell sheet forma–tion and tissue regeneration by elevating telomerase activi–ty, J. Cell Physiol., 227, 3216–3224.
Lin, T. M., Tsai, J. L., Lin, S. D., Lai, C. S., and Chang, C. C. (2005) Accelerated growth and prolonged lifespan of adipose tissue–derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants, Stem Cells Dev., 14, 92–102.
Skulachev, V. P. (2013) Cationic antioxidants as a powerful tool against mitochondrial oxidative stress, Biochem. Biophys. Res. Commun., 441, 275–279.
Skulachev, M. V., and Skulachev, V. P. (2017) Programmed aging of mammals: proof of concept and prospects of bio–chemical approaches for anti–aging therapy, Biochemistry (Moscow), 82, 1403–1422.
Fehrer, C., Brunauer, R., Laschober, G., Unterluggauer, H., Reitinger, S., Kloss, F., Gully, C., Gassner, R., and Lepperdinger, G. (2007) Reduced oxygen tension attenu–ates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan, Aging Cell., 6, 745–757.
Choi, J. R., Pingguan–Murphy, B., Wan Abas, W. A., Yong, K. W., Poon, C. T., Noor Azmi, M. A., Omar, S. Z., Chua, K. H., Xu, F., and Wan Safwani, W. K. (2015) In situ nor–moxia enhances survival and proliferation rate of human adipose tissue–derived stromal cells without increasing the risk of tumorigenesis, PLoS One, 10, e0115034.
Buravkova, L. B., Andreeva, E. R., Gogvadze, V., and Zhivotovsky, B. (2014) Mesenchymal stem cells and hypox–ia: where are we? Mitochondrion, 19, 105–112.
Lobanova, M. V., Ratushnyy, A. Y., and Buravkova, L. B. (2016) Expression of senescence–associated genes in multi–potent mesenchymal stromal cells during long–term culti–vation at various hypoxic levels, Dokl. Biochem. Biophys., 470, 326–328.
Ratushnyy, A., Lobanova, M., and Buravkova, L. B. (2017) Expansion of adipose tissue–derived stromal cells at “phys–iologic” hypoxia attenuates replicative senescence, Cell Biochem. Funct., 35, 232–243.
Semenza, G. L. (2007) Hypoxia–inducible factor 1 (HIF–1) pathway, Sci. STKE, 2007, cm8.
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., and Hedrick, M. H. (2001) Multilineage cells from human adipose tissue: implications for cell–based therapies, Tissue Eng., 7, 211–228.
Buravkova, L. B., Grinakovskaya, O. S., Andreeva, E. R., Zhambalova, A. P., and Kozionova, M. P. (2009) Characteristics of human lipoaspirate–isolated mesenchy–mal stromal cells cultivated under lower oxygen tension, Tsitologiya, 51, 4–10.
Dominici, M., Le Blanc, K., Mueller, I., Slaper–Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D. J., and Horwitz, E. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315–317.
Greenwood, S. K., Hill, R. B., Sun, J. T., Armstrong, M. J., Johnson, T. E., Gara, J. P., and Galloway, S. M. (2004) Population doubling: a simple and more accurate estima–tion of cell growth suppression in the in vitro assay for chro–mosomal aberrations that reduces irrelevant positive results, Environ. Mol. Mutagen., 43, 36–44.
Livak, K. J., and Schmittgen, T. D. (2001) Analysis of rela–tive gene expression data using real–time quantitative PCR and the 2–ΔΔCT method, Methods, 25, 402–408.
McLeod, C. M., and Mauck, R. L. (2017) On the origin and impact of mesenchymal stem cell heterogeneity: new insights and emerging tools for single cell analysis, Eur. Cell Mater., 34, 217–231.
Gonzalez–Cruz, R. D., Fonseca, V. C., and Darling, E. M. (2012) Cellular mechanical properties reflect the differenti–ation potential of adipose–derived mesenchymal stem cells, Proc. Natl. Acad. Sci. USA, 109, E1523–E1529.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira–Smith, O., Peacocke, M., and Campisi, J. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. USA, 92, 9363–9367.
Xu, L. N., Lin, N., Xu, B. N., Li, J. B., and Chen, S. Q. (2015) Effect of human umbilical cord mesenchymal stem cells on endometriotic cell proliferation and apoptosis, Genet. Mol. Res., 14, 16553–16561.
Bakkenist, C. J., and Kastan, M. B. (2004) Phosphatases join kinases in DNA–damage response pathways, Trends Cell Biol., 14, 339–341.
Zhan, H., Suzuki, T., Aizawa, K., Miyagawa, K., and Nagai, R. (2010) Ataxia telangiectasia mutated (ATM)–mediated DNA damage response in oxidative stress–induced vascular endothelial cell senescence, J. Biol. Chem., 285, 29662–29670.
Buscemi, G., Perego, P., Carenini, N., Nakanishi, M., Chessa, L., Chen, J., Khanna, K., and Delia, D. (2004) Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks, Oncogene, 23, 7691–7700.
Lukas, C., Falck, J., Bartkova, J., Bartek, J., and Lukas, J. (2003) Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage, Nat. Cell Biol., 5, 255–260.
Von Zglinicki, T., Saretzki, G., Ladhoff, J., d’Adda di Fagagna, F., and Jackson, S. P. (2005) Human cell senes–cence as a DNA damage response, Mech. Ageing Dev., 126, 111–117.
Sofer, A., Lei, K., Johannessen, C. M., and Ellisen, L. W. (2005) Regulation of mTOR and cell growth in response to energy stress by REDD1, Mol. Cell Biol., 25, 5834–5845.
Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., Kalinski, H., Kamer, I., Rozen, A., Mor, O., Keshet, E., Leshkowitz, D., Einat, P., Skaliter, R., and Feinstein, E. (2002) Identification of a novel hypoxia–inducible factor 1–responsive gene, RTP801, involved in apoptosis, Mol. Cell Biol., 22, 2283–2293.
Wolff, N. C., Vega–Rubin–de–Celis, S., Xie, X. J., Castrillon, D. H., Kabbani, W., and Brugarolas, J. (2011) Cell–type–dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia, J. Mol. Cell Biol., 31, 1870–1884.
Kucejova, B., Sunny, N. E., Nguyen, A. D., Hallac, R., Fu, X., Pena–Llopis, S., Mason, R. P., Deberardinis, R. J., Xie, X. J., Debose–Boyd, R., Kodibagkar, V. D., Burgess, S. C., and Brugarolas, J. (2011) Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death, Oncogene, 30, 2147–2160.
Benita, Y., Kikuchi, H., Smith, A. D., Zhang, M. Q., Chung, D. C., and Xavier, R. J. (2009) An integrative genomics approach identifies hypoxia inducible factor–1 (HIF–1)–target genes that form the core response to hypox–ia, Nucleic Acids Res., 37, 4587–4602.
Murakami, S., Terakura, M., Kamatani, T., Hashikawa, T., Saho, T., Shimabukuro, Y., and Okada, H. (2000) Adenosine regulates the production of interleukin–6 by human gingival fibroblasts via cyclic AMP/protein kinase A pathway, J. Periodont. Res., 35, 93–101.
Ray, R., Chen, G., Vande Velde, C., Cizeau, J., Park, J. H., Reed, J. C., Gietz, R. D., and Greenberg, A. H. (2000) BNIP3 heterodimerizes with Bcl–2/Bcl–X(L) and induces cell death independent of a Bcl–2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites, J. Biol. Chem., 275, 1439–1448.
Ahmed, S., Al–Saigh, S., and Matthews, J. (2012) FOXA1 is essential for aryl hydrocarbon receptor–dependent regu–lation of cyclin G2, Mol. Cancer Res., 10, 636–648.
Sun, G. G., Zhang, J., and Hu, W. N. (2014) CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance, Tumour Biol., 35, 3339–3346.
Huang, H. Y., Chen, S. Z., Zhang, W. T., Wang, S. S., Liu, Y., Li, X., Sun, X., Li, Y. M., Wen, B., Lei, Q. Y., and Tang, Q. Q. (2013) Induction of EMT–like response by BMP4 via up–regulation of lysyl oxidase is required for adipocyte lin–eage commitment, Stem Cell Res., 10, 278–287.
Kortlever, R. M., Higgins, P. J., and Bernards, R. (2006) Plasminogen activator inhibitor–1 is a critical downstream target of p53 in the induction of replicative senescence, Nat. Cell Biol., 8, 877–884.
Zhang, Y., Xu, Y., Ma, J., Pang, X., and Dong, M. (2017) Adrenomedullin promotes angiogenesis in epithelial ovari–an cancer through upregulating hypoxia–inducible factor–1α and vascular endothelial growth factor, Sci. Rep., 7, 40524.
Chen, K., and Maines, M. D. (2000) Nitric oxide induces heme oxygenase–1 via mitogen–activated protein kinases ERK and p38, Cell Mol. Biol. (Noisy–le–grand), 46, 609–617.
Pescador, N., Villar, D., Cifuentes, D., Garcia–Rocha, M., Ortiz–Barahona, A., Vazquez, S., Ordonez, A., Cuevas, Y., Saez–Morales, D., Garcia–Bermejo, M. L., Landazuri, M. O., Guinovart, J., and del Peso, L. (2010) Hypoxia pro–motes glycogen accumulation through hypoxia inducible factor (HIF)–mediated induction of glycogen synthase 1, PLoS One, 5, e9644.
Kim, I., Kim, H. G., Kim, H., Kim, H. H., Park, S. K., Uhm, C. S., Lee, Z. H., and Koh, G. Y. (2000) Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin–related protein that prevents endothelial cell apoptosis, Biochem. J., 346, 603–610.
Pogodina, M. V., and Buravkova, L. B. (2015) Expression of HIF–1α in multipotent mesenchymal stromal cells under hypoxic conditions, Bull. Exp. Biol. Med., 159, 355–357.
Tsai, C. C., Chen, Y. J., Yew, T. L., Chen, L. L., Wang, J. Y., Chiu, C. H., and Hung, S. C. (2011) Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down–regulation of E2A–p21 by HIF–TWIST, Blood, 117, 459–469.
Author information
Authors and Affiliations
Corresponding author
Additional information
Russian Text © A. Yu. Ratushnyy, Yu. V. Rudimova, L. B. Buravkova, 2019, published in Biokhimiya, 2019, Vol. 84, No. 3, pp. 380–391.
Rights and permissions
About this article
Cite this article
Ratushnyy, A.Y., Rudimova, Y.V. & Buravkova, L.B. Alteration of Hypoxia-Associated Gene Expression in Replicatively Senescent Mesenchymal Stromal Cells under Physiological Oxygen Level. Biochemistry Moscow 84, 263–271 (2019). https://doi.org/10.1134/S0006297919030088
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297919030088